Crystal Parney|April 3, 2024Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024
Crystal Parney|April 3, 2024Ensuring compliance with the False Claims Act has never been more important for healthcare providers.
